(OVID) Ovid Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Ovid Therapeutics | (OVID) share price targets
Complete technical analysis of Ovid Therapeutics (OVID) by charts plus indicators, forecast predictions and share price targets for Ovid Therapeutics (OVID)
Ovid Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Ovid Therapeutics is 831600
| Date | Daily Closing Price | Open | High | Low | Volume |
| 14 Wed Apr 2021 | 3.85 | 3.68 | 3.96 | 3.67 | 0.768 times |
| 13 Tue Apr 2021 | 3.66 | 3.60 | 3.70 | 3.59 | 0.907 times |
| 12 Mon Apr 2021 | 3.61 | 3.70 | 3.71 | 3.56 | 1.05 times |
| 09 Fri Apr 2021 | 3.69 | 3.75 | 3.83 | 3.68 | 0.877 times |
| 08 Thu Apr 2021 | 3.69 | 3.74 | 3.83 | 3.69 | 1.011 times |
| 07 Wed Apr 2021 | 3.74 | 3.81 | 3.92 | 3.72 | 0.565 times |
| 06 Tue Apr 2021 | 3.83 | 3.97 | 3.98 | 3.81 | 1.27 times |
| 05 Mon Apr 2021 | 3.99 | 4.03 | 4.12 | 3.90 | 0.984 times |
| 01 Thu Apr 2021 | 4.07 | 4.03 | 4.14 | 3.97 | 1.18 times |
| 31 Wed Mar 2021 | 4.02 | 3.81 | 4.08 | 3.81 | 1.037 times |
My analysis of stock is bearish for shortterm, and stock might move down till 3.7 or till 3.4. Use a stoploss of 3.95 and if the stock hits stoploss, then it can shoot up till 4.18
Share price targets for Ovid Therapeutics (OVID)
| Target Type | Value |
| Downside Target | 2.25 |
| Downside Target | 2.58 |
| Downside Target | 2.95 |
| Downside Target | 3.08 |
| Downside Target | 3.56 |
| Downside Target | 3.68 |
| Downside Target | 3.76 |
| Upside Target | 3.96 |
| Upside Target | 4.12 |
| Upside Target | 4.14 |
| Upside Target | 4.45 |
| Upside Target | 4.53 |
| Upside Target | 4.75 |
| Upside Target | 6.98 |
Intraday share price targets for Ovid Therapeutics (OVID)
| Target Type | Value |
| Downside Intraday Target | 3.62 |
| Downside Intraday Target | 3.39 |
| Upside Intraday Target | 4.02 |
| Upside Intraday Target | 4.19 |
| Downside Intraday Target | 3.79 |
Weekly technical analysis of Ovid Therapeutics (OVID)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 14 Wed Apr 2021 | 3.85 | 3.70 | 3.96 | 3.56 | 0.579 times |
| 09 Fri Apr 2021 | 3.69 | 4.03 | 4.12 | 3.68 | 1.034 times |
| 01 Thu Apr 2021 | 4.07 | 3.93 | 4.14 | 3.77 | 0.638 times |
| 26 Fri Mar 2021 | 3.97 | 4.44 | 4.45 | 3.76 | 0.593 times |
| 19 Fri Mar 2021 | 4.47 | 4.06 | 4.53 | 3.97 | 0.85 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Ovid Therapeutics (OVID)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 14 Wed Apr 2021 | 3.85 | 4.03 | 4.14 | 3.56 | 0.041 times |
| 31 Wed Mar 2021 | 4.02 | 3.02 | 4.75 | 2.95 | 3.759 times |
| 26 Fri Feb 2021 | 2.95 | 2.80 | 3.97 | 2.58 | 1.31 times |
| 29 Fri Jan 2021 | 2.81 | 2.34 | 3.08 | 2.27 | 0.522 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Ovid Therapeutics (OVID)
| Indicator Name | Indicator Value | Indicator Signal |
| ADX | 32, 23, 17 | Buy |
| MACD | 0, 0 | Sell |
| Stochastics | 25 | Sell |
| CCI | -0 | Buy |
| RSI | 53 | Buy |
| OBV | -467800 | Sell |
| VWAP | 4 | Buy |
| ADL | 0 | Sell |
| ROC | 0 | Sell |
| Force Index | 0 | Sell |
Price action analysis of Ovid Therapeutics ( (OVID) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Ovid Therapeutics ( (OVID) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ovid Therapeutics ( (OVID) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ovid Therapeutics ( (OVID) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Ovid Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Ovid Therapeutics in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Ovid Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Ovid Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Ovid Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.83 and Ovid Therapeutics (OVID) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Ovid Therapeutics (OVID) stock. Volume based technical analysis of Ovid Therapeutics (OVID) stock is negative.
Ovid Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Daily charts
NSE Gainers NSE Losers BSE Gainers BSE Losers
Munafa NEWS FeedTerms of Use Powered by ePowerPress Stock Market News!
© munafa.top2021 All Rights reserved.